NMRA- Neumora Therapeutics, Inc.

Name: Neumora Therapeutics, Inc. Insider Trading Data
Creator: U.S. Securities and Exchange Commission
License: https://www.sec.gov/privacy#accessibility

Neumora Therapeutics, Inc. (NMRA) has 12 insiders with recent SEC Form 4 filings, including 17 buys and 9 sells. NMRA is classified in the Biotechnology industry within the Health Care sector.

Insider Ownership

Role	Insider	Shares	Value	30d
10%	Arch Venture Partners X, LLC	6.05M	$11.28M	-
10%	Burow Kristina	6.05M	$11.28M	-
10%	Arch Venture Partners Xii, LLC	6.05M	$11.28M	-
Other	Berns Paul L	1.65M	$3.08M	-
Pres	Pinto Joshua	1.20M	$2.24M	-

Activity

Buys and sells only

Transactions

10 filings · page 2

Date	Insider	Role	Type	Shares	Price	Value	Chg%	3M	12M
Oct 10, 2024	Lenz Robert A.80	Head Of R&D	Sell	13,823	$15.06	$208,110.23	-2.1%	-84.6%	-87.7%
Sep 18, 2024	Lenz Robert A.80	Head Of R&D	Sell	41,464	$11.89	$492,826.58	-5.8%	-11.0%	-87.1%
Sep 12, 2024	Lenz Robert A.80	Head Of R&D	Sell	32,948	$11.43	$376,664.83	-8.2%	-11.1%	-86.3%
Aug 27, 2024	Pinto Joshua74	Chief Financial Officer	Sell	15,693	$11.39	$178,806.04	-10.1%	-16.3%	-84.8%
Aug 26, 2024	Pinto Joshua74	Chief Financial Officer	Sell	84,307	$11.67	$984,061.15	-13.3%	-17.4%	-85.1%
Nov 14, 2023	Burow Kristina68	Director, 10% Owner	Buy	35,010	$11.77	$412,139.61	+0.4%	+52.3%	-9.1%
Nov 14, 2023	Arch Venture Partners Xii, LLC63	10% Owner	Buy	35,010	$11.77	$412,139.61	+0.4%	+52.3%	-9.1%
Nov 10, 2023	Burow Kristina68	Director, 10% Owner	Buy	140,605	$10.98	$1,543,563.42	+0.7%	+50.7%	+16.9%
Nov 10, 2023	Arch Venture Partners Xii, LLC63	10% Owner	Buy	140,605	$10.98	$1,543,563.42	+0.7%	+50.7%	+16.9%
Nov 7, 2023	Burow Kristina68	Director, 10% Owner	Buy	95,694	$11.49	$1,099,944.70	+0.8%	+30.9%	+9.6%

← PrevPage 2Next →

Insider	Role	Shares	Value	Buys	Sells

Date	Ticker	Insider	Role	Type	Shares	Price	Value	Chg%	SEC